Literature DB >> 25518338

[Mechanism of prostate cancer invasion and metastasis].

Shinichi Sakamoto, Tomohiko Ichikawa.   

Abstract

Prostate cancer cells pass through numerous steps during the process of progression and metastasis. Cancer cells from primary site undertake "epithelial-mesenchymal transition (EMT)" and migrate into neighboring site and invade into blood vessels. Migrated cancer cells will detach from extracellular matrix (ECM) and float into distant metastasis site. Those detached cells will go through either "apoptosis" or acquire "anoikis resistance" and, finally, transfer to distant metastasis site. When settle at novel metastasis site, "mesenchymal-epithelial transition (MET)" will take place. Receptor activator of nuclear factor κ-B ligand (RANKL) plays significant role in formation of bone metastasis site.

Entities:  

Mesh:

Year:  2014        PMID: 25518338

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  3 in total

Review 1.  MicroRNA-338-3p suppresses metastasis of lung cancer cells by targeting the EMT regulator Sox4.

Authors:  Yang Li; Peirui Chen; Lingling Zu; Bin Liu; Min Wang; Qinghua Zhou
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

2.  MTA1 drives malignant progression and bone metastasis in prostate cancer.

Authors:  Avinash Kumar; Swati Dhar; Gisella Campanelli; Nasir A Butt; Jason M Schallheim; Christian R Gomez; Anait S Levenson
Journal:  Mol Oncol       Date:  2018-08-14       Impact factor: 6.603

Review 3.  The regulatory roles of lncRNAs in the process of breast cancer invasion and metastasis.

Authors:  Siying Zhou; Yunjie He; Sujin Yang; Jiahua Hu; Qian Zhang; Wei Chen; Hanzi Xu; Heda Zhang; Shanliang Zhong; Jianhua Zhao; Jinhai Tang
Journal:  Biosci Rep       Date:  2018-09-28       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.